Target intelligence / Profile preview

Glutamate-gated chloride channel (parasite) (GluCl)

Target
GluCl
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor superfamily
01

Overview

Glutamate-gated chloride channels (GluCl) are pentameric ligand-gated ion channels found exclusively in protostome invertebrates, such as nematodes, arthropods, and certain mollusks and flatworms. Each channel consists of five subunits, each with an N-terminal extracellular ligand-binding domain (for glutamate) and four transmembrane helices. Upon glutamate binding, the channel opens to allow chloride ion influx, resulting in neuronal hyperpolarization and inhibition of excitability. GluCl channels are the principal molecular targets for macrocyclic lactone anthelmintics (such as ivermectin), which act as potent agonists and allosteric modulators by binding within the transmembrane region and causing persistent channel opening. The resulting paralysis and death of the parasite make GluCl a critical target for both veterinary and human antiparasitic therapies. GluCl is absent in vertebrates, contributing to the selectivity and safety of the drugs, although resistance and rare toxicity are ongoing challenges.

Other names
GluCl channelGluCl receptorIvermectin-sensitive chloride channel
02

Mechanism of action

Positive allosteric modulation and agonism: macrocyclic lactones (e.g., ivermectin) bind GluCl and cause persistent opening of the chloride channel, leading to sustained chloride influx, hyperpolarization of neuronal or muscle membranes, paralysis, and death of the parasite.

03

Biological functions

Inhibitory neurotransmission in invertebratesRegulation of locomotionControl of feeding behaviorMediation of sensory input into behavior
04

Disease associations

Infection (target for antiparasitic and insecticidal therapy)
05

Safety considerations

Host toxicity: generally low in mammals due to absence of GluCl in vertebrates, but CNS toxicity may occur in certain mammals (e.g., dogs with MDR1 mutations) due to blood-brain barrier defectsResistance: emerging resistance to macrocyclic lactones in parasitic nematodes
06

Interacting drugs

Ivermectin

4 more in the full profile.

Beyond the preview

Go deeper on Glutamate-gated chloride channel (parasite) (GluCl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-gated chloride channel (parasite) (GluCl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call